Design, synthesis and evaluation of an uncharged broad spectrum quinoline-oxime hybrid for the reactivation of nerve agent-inhibited human acetylcholinesterase
DD [auth B] ED [auth B] F [auth A] FD [auth B] G [auth A]
DD [auth B], ED [auth B], F [auth A], FD [auth B], G [auth A], GD [auth B], H [auth A], HD [auth B], I [auth A], ID [auth B], J [auth A], JD [auth B], K [auth A], KD [auth B], L [auth A], LD [auth B], M [auth A], MD [auth B], N [auth A], ND [auth B], O [auth A], OD [auth B], P [auth A], Q [auth A], R [auth A]
AA [auth A] QD [auth B] RD [auth B] S [auth A] SD [auth B]
AA [auth A], QD [auth B], RD [auth B], S [auth A], SD [auth B], T [auth A], U [auth A], UD [auth B], V [auth A], VD [auth B], W [auth A], X [auth A], Y [auth A], Z [auth A]
AE [auth B] BE [auth B] CE [auth B] DA [auth A] DE [auth B]
AE [auth B], BE [auth B], CE [auth B], DA [auth A], DE [auth B], EA [auth A], EE [auth B], FA [auth A], FE [auth B], GA [auth A], GE [auth B], HA [auth A], HE [auth B], IA [auth A], IE [auth B], JA [auth A], JE [auth B], KA [auth A], KE [auth B], LA [auth A], LE [auth B], MA [auth A], ME [auth B], NA [auth A], NE [auth B], OA [auth A], OE [auth B], PA [auth A], PE [auth B], QA [auth A], QE [auth B], RA [auth A], RE [auth B], SA [auth A], SE [auth B], TA [auth A], TE [auth B], UA [auth A], UE [auth B], VA [auth A], XD [auth B], YD [auth B], ZD [auth B]